Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

The goal is to educate the public and professionals about AMD and support patients and families affected by vision impairment ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with fewer treatments based on its continuous delivery of a customized formulation ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), a biopharmaceutical ...

Our vision declines as we age leading to the development of various eye conditions such as presbyopia cataracts and glaucoma ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Modern cataract surgery is a safe, effective procedure, but it wasn't always this way. The earliest record dates back to the fifth century BC.

In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular edema ...

New research found that high levels of ‘good cholesterol’ in the blood were associated with an increased risk of glaucoma, an ...

Elizabeth “Beth” Noble, Ph.D. of education, prides herself in being a devout promoter of Jewish Family Services’ (JFS) services. She is an advocate, donor and client.